More on Valeant (VRX +2.3%) Q1: Swings to net loss of $12.9M from a profit of $6.5M after taking...

|About: Valeant Pharmaceuticals I... (VRX)|By:, SA News Editor

More on Valeant (VRX +2.3%) Q1: Swings to net loss of $12.9M from a profit of $6.5M after taking increased provisions for restructuring and acquisition-related costs, and other charges. To buy assets from University Medical Pharmaceuticals, which focuses on skincare, for $64M and milestone payments.